澳大利亚流感疫苗属性与成本偏好:一项离散选择实验

澳大利亚流感疫苗偏好离散选择实验数据集,包含1203名成年人对疫苗保护效果、匹配度、成本等属性的偏好数据。

Taylor & FrancisTaylor & Francis
DataCite Commons
2026-03-17 更新
浏览 19
文本Seasonal influenzainfluenza vaccine choicepatient preferencesdiscrete choice experimentcell-based vaccines疫苗编码
Australian preferences for influenza vaccine attributes and cost: A discrete choice experiment

基本信息

模态
文本
大小
0.000031942 GB
许可
CC BY-NC-ND 4.0
创建/更新时间
2026-03-17
版本
v1

资源简介

澳大利亚流感疫苗属性与成本偏好:一项离散选择实验

【一句话概览】

本数据集是 figshare 公开的文本数据集,收录 2 个文件、合计 31.94 KB,主题涵盖 Seasonal influenza、influenza vaccine choice、patient preferences、discrete choice experiment、cell-based vaccines,可用于医学自然语言处理(实体识别、信息抽取等),CC BY-NC-ND 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Australian preferences for influenza vaccine attributes and cost: A discrete choice experiment》。配套论文《Australian preferences for influenza vaccine attributes and cost: A discrete choice experiment》发表于 Human Vaccines & Immunotherapeutics(2024),DOI:10.1080/21645515.2024.2440164。项目资助方:The study was funded by CSL Seqirus Ltd who were not part of the overall study design. Members of the companies were involved in the final discussion of results and dissemination. Funding bodies had no specific role in data collection, or data analysis. DY, KY and JM are employees of CSL Seqirus. SF and LT are from CaPPRe who were contracted by CSL Seqirus to design the experiment, provide data management, conduct the analysis and write the manuscript. CaPPRe has consulted to AbbVie, Amgen, AstraZeneca, BMS, Celgene, CSL Behring, Edwards, Gilead, GSK, Ipsen, Janssen, MSD, Novo Nordisk, Roche, Sanofi, Shire, Takeda, UCB and Vertex, outside of the submitted work.。源站首次发布:2024-12-21。

【数据内容】

源站原始描述:People in Australia have access to different influenza vaccines, but may be unaware of their options and features. Preference studies for differentiated influenza vaccines including cell-based vaccines are limited, particularly in Australia. This study investigated which influenza vaccine attributes people in Australia value using a discrete choice experiment (DCE). Adults in Australia ineligible for free influenza vaccines had been vaccinated in the last 5 years and intended to be vaccinated ag…

【数据结构与技术规格】

文件数 2 个,合计 31.94 KB。khvi_a_2440164_sm9035.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,15.13 KB。khvi_a_2440164_sm9034.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,16.81 KB。数据集 DOI:10.6084/m9.figshare.28077389.v1。

【主题与分类】

源站学科分类:Medicine、Biotechnology、Sociology、Cancer、Science Policy、Infectious Diseases。主题标签:Seasonal influenza、influenza vaccine choice、patient preferences、discrete choice experiment、cell-based vaccines。

【适用方向】

文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/Australian_preferences_for_influenza_vaccine_attributes_and_cost_A_discrete_choice_experiment/28077389

使用许可:CC BY-NC-ND 4.0(https://creativecommons.org/licenses/by-nc-nd/4.0/)。

规范引用:Australian preferences for influenza vaccine attributes and cost: A discrete choice experiment. Taylor & Francis. Fifer, Simon; Toh, Lili; Yu, Daniel; Young, Katherine; Menche, Jason

【使用注意】

· 源站最后修改于 2026-09-15,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "khvi_a_2440164_sm9035.docx" "https://ndownloader.figshare.com/files/51339635"
curl -L -o "khvi_a_2440164_sm9034.docx" "https://ndownloader.figshare.com/files/51339638"

文件清单

  • khvi_a_2440164_sm9035.docx(15.13 KB)
  • khvi_a_2440164_sm9034.docx(16.81 KB)

文件总体积 31.94 KB(源站 API 实测)。

数据说明

People in Australia have access to different influenza vaccines, but may be unaware of their options and features. Preference studies for differentiated influenza vaccines including cell-based vaccines are limited, particularly in Australia. This study investigated which influenza vaccine attributes people in Australia value using a discrete choice experiment (DCE). Adults in Australia ineligible for free influenza vaccines had been vaccinated in the last 5 years and intended to be vaccinated again completed an online survey. Participants (N = 1203) were presented three influenza vaccine profiles described by eight attributes. Half the DCE scenarios described influenza season severity to be the same as last year, and the other half as more severe. DCE data were analyzed using a mixed multinomial logit (MMNL) model. All eight attributes significantly predicted vaccine choice (p < .05). Regardless of influenza season severity, participants preferred a vaccine: with greater protection, designed to be an exact match to circulating strains (match), using modern technology, manufactured by an Australian company, available at pharmacies, preferred by health care professionals (HCP), government funded for high-risk individuals and having lower cost. The top three attributes by importance were protection, match and cost. Participants were willing to pay more for match and higher protection. The Marginal Willingness to Pay (MWTP) for the most important attributes, excluding cost, were AUD $1.61/$2.18 for each additional percent in protection (same/more severe season), AUD $25.37/$32.37 for match and AUD $4.06/$15.97 for HCP preference. Findings indicate that match, protection, cost and HCP preference are key to vaccine choice, highlighting the importance of shared decision-making.

许可

CC BY-NC-ND 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.28077389.v1(source: https://tandf.figshare.com/articles/dataset/Australian_preferences_for_influenza_vaccine_attributes_and_cost_A_discrete_choice_experiment/28077389)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案